Stockpiling antiviral medications for pandemic influenza

An antiviral stockpile is a reserve supply of essential antiviral medications in case of shortage. Many countries have chosen to stockpile antiviral medications against pandemic influenza.[1] Because of the time required to prepare and distribute an influenza vaccine, these stockpiles are the only medical defense against widespread infection for the first six months.[2] The stockpiles may be in the form of capsules or simply as the active pharmaceutical ingredient, which is stored in sealed drums and, when needed, dissolved in water to make a bitter-tasting, clear liquid.[3]

There are no evidence-based guidelines to guide the use of these stockpiled drugs,[1] and plans are based on assumed similarities to seasonal influenza. The most common antivirals are neuraminidase inhibitors, which, if begun during the first 48 hours after symptoms appear, will reduce the duration of seasonal influenza by about one day. Taken before symptoms appear, it may prevent disease in about three-quarters of people treated prophylactically.[4] Currently, this is recommended in institutionalized elderly people and other high-risk groups as a form of post-exposure prophylaxis during seasonal influenza outbreaks.[2] However, since pandemic influenza differs somewhat from normal seasonal influenza, it is not clear that these drugs will prove either safe or effective for their intended purpose.[4]

For a person who has very recently been exposed to seasonal influenza, effective post-exposure prophylaxis generally requires taking a drug like oseltamivir for seven to ten days, at half the daily dose needed for treatment. A person that is repeatedly exposed, such as hospital staff members, may require continuous treatment throughout the duration of the outbreak in a community. Based on experience with seasonal influenza in nursing homes, control of influenza requires full treatment of any ill persons and prophylactic treatment of all their contacts. In a pandemic situation, before a vaccine becomes available, this level of treatment and medical prevention may require providing drugs to 80% of the people in an affected community.[3] Consequently, very large supplies of the drugs must be made available — much larger supplies than could be produced on demand. Stockpiles are generally arranged in advance by government health authorities, due to fear of shortages and an awareness of manufacturing limitations during an outbreak.[3]

Supplies in each country

edit

List of available treatments of antiviral per country.

Rank Country / Territory Population Treatments Date Last Updated Source
1   China 1,337,722,000
2   India 1,402,150,000
3   United States 337,158,000 50,000,000 April 27, 2009 Bloomberg.com
Report of antiviral stockpile sales
4   Indonesia 230,014,115
5   Brazil 229,994,512
6   Pakistan 166,146,000
7   Bangladesh 162,221,000
8   Nigeria 154,729,000
9   Russia 141,833,393
10   Japan 127,630,000 47,700,000 November 27, 2017 Ministry of Health, Labour and Welfare
[1]
11   Mexico 109,610,000
12   Philippines 92,226,600
13   Vietnam 88,069,000
14   Germany 82,062,200
15   Ethiopia 79,221,000
16   Egypt 76,030,000
17   Turkey 71,517,100
18   Iran 70,495,782
19   Dem. Rep. of Congo 66,020,000
20   France 65,073,482
21   Thailand 63,389,730
22   United Kingdom 61,612,300 30,000,000 April 28, 2009 BBC News
Swine flu: How serious a threat?
23   Italy 60,090,400
24   Myanmar 50,020,000
25   South Africa 48,697,000
26   South Korea 48,333,000 21,100,000 August 21, 2009 The Korea Times
More Flu Virus Vaccines to Be Stockpiled
27   Ukraine 46,143,700
28   Spain 45,853,000
29   Colombia 44,830,423
30   Tanzania 43,739,000
31   Sudan 42,272,000
32   Kenya 39,802,000
33   Argentina 39,745,613
34   Poland 38,130,300
35   Algeria 34,895,000
36   Canada 33,476,688 1,400,000 April 27, 2009 Bloomberg.com
Report of Antiviral Stockpile Sales
37   Uganda 32,710,000
38   Morocco 31,394,044
39   Iraq 30,747,000
40     Nepal 29,331,000
41   Peru 29,165,000
42   Venezuela 28,685,400
43   Malaysia 28,200,000
44   Afghanistan 28,150,000
45   Uzbekistan 27,488,000
46   Saudi Arabia 25,721,000
47   North Korea 23,906,000
48   Ghana 23,837,000
49   Yemen 23,580,000
50   Taiwan 23,027,672
51   Mozambique 22,894,000
52   Syria 21,906,000
53   Australia 21,745,000
54   Romania 21,496,700
55   Côte d'Ivoire 21,075,000
56   Sri Lanka 20,238,000
57   Madagascar 19,625,000
58   Cameroon 19,522,000
59   Angola 18,498,000
60   Chile 19,474,000 950,000 June 6, 2009 Ministerio de Salud de Chile
Nueva Influenza Humana A (H1N1)
61   Netherlands 16,508,734
62   Burkina Faso 15,757,000
63   Kazakhstan 15,571,506
64   Niger 15,290,000
65   Malawi 15,263,000
66   Guatemala 14,027,000
67   Ecuador 13,938,115
68   Cambodia 13,388,910
69   Mali 13,010,000
70   Zambia 12,935,000
71   Senegal 12,534,000
72   Zimbabwe 12,523,000
73   Greece 11,262,500
74   Chad 11,206,000
75   Cuba 11,204,000
76   Belgium 10,741,000 3,000,000 1 Jan. 2007 Influenza [2]
77   Portugal 10,631,800
78   Czech Republic 10,474,600
79   Tunisia 10,327,800
80   Dominican Republic 10,090,000
81   Guinea 10,069,000
82   Haiti 10,033,000
83   Hungary 10,029,900
84   Rwanda 9,998,000
85   Bolivia 9,863,000
86   Serbia 9,850,000
87   Belarus 9,690,000
88   Sweden 9,264,000
89   Somalia 9,133,000
90   Benin 8,935,000
91   Azerbaijan 8,629,900
92   Austria 8,356,700
93   Burundi 8,303,000
94    Switzerland 7,705,800
95   Bulgaria 7,602,100
96   Honduras 7,466,000
97   Israel 7,411,000
98   Tajikistan 6,952,000
99   Papua New Guinea 6,732,000
100   Togo 6,619,000
101   Libya 6,420,000
102   Paraguay 6,349,000
103   Laos 6,320,000
104   Jordan 6,316,000
105   El Salvador 6,163,000
106   Nicaragua 5,743,000
107   Sierra Leone 5,696,000
108   Denmark 5,511,451
109   Kyrgyzstan 5,482,000
110   Slovakia 5,411,100
111   Finland 5,333,089
112   Turkmenistan 5,110,000
113   Eritrea 5,073,000
114   Singapore 4,839,400 500,000 April 28, 2009 Referenced. Confirmation expected.
115   Norway 4,814,075 1,400,000 April 28, 2009 [3]
116   United Arab Emirates 4,599,000
117   Costa Rica 4,579,000 3,000 April 28, 2009 Nacion.com (Spanish)
118   Ireland 4,517,800
119   Croatia 4,432,000
120   Central African Republic 4,422,000
121   Georgia 4,382,100
122   New Zealand 4,306,500
123   Lebanon 4,224,000
124   Puerto Rico (US) 3,982,000
125   Liberia 3,955,000
126   Bosnia and Herzegovina 3,767,000
127   Palestine 3,761,646
128   Republic of the Congo 3,683,000
129   Moldova 3,572,700
130   Panama 3,454,000
131   Uruguay 3,361,000
132   Lithuania 3,350,400
133   Mauritania 3,291,000
134   Armenia 3,230,100
135   Albania 3,170,000
136   Kuwait 2,985,000
137   Oman 2,845,000
138   Jamaica 2,719,000
139   Mongolia 2,671,000
140   Latvia 2,259,400
141   Namibia 2,171,000
142   Lesotho 2,067,000
143   Slovenia 2,053,355
144   North Macedonia 2,048,900
145   Botswana 1,950,000
146   Gambia 1,705,000
147   Guinea-Bissau 1,611,000
148   Gabon 1,475,000
149   Qatar 1,409,000
150   Estonia 1,340,341
151   Trinidad and Tobago 1,339,000
152   Mauritius 1,288,000
153   Eswatini (Swaziland) 1,185,000
154   East Timor 1,134,000
155   Djibouti 864,000
156   Fiji 849,000
157   Cyprus 801,600
158   Bahrain 791,000
159   Guyana 762,000
160   Bhutan 697,000
161   Comoros 676,000
162   Equatorial Guinea 676,000
163   Montenegro 624,000
164   Solomon Islands 523,000
165   Suriname 520,000
166   Western Sahara 513,000
167   Cape Verde 506,000
168   Luxembourg 491,700
169   Malta 412,600
170   Brunei 400,000
171   Bahamas 342,000
172   Iceland 319,326
173   Maldives 309,000
174   Belize 307,000
175   Barbados 256,000
176   Vanuatu 240,000
177   Netherlands Antilles (Netherlands) 198,000
178   Samoa 179,000
179   Guam (US) 178,000
180   Saint Lucia 172,000
181   São Tomé and Príncipe 163,000
182   Federated States of Micronesia 111,000
183   U.S. Virgin Islands (US) 110,000
184   Saint Vincent and the Grenadines 109,000
185   Aruba (Netherlands) 107,000
186   Grenada 104,000
187   Tonga 104,000
188   Kiribati 98,000
189   Jersey (US) 89,300
190   Antigua and Barbuda 88,000
191   Northern Mariana Islands (US) 87,000
192   Andorra 86,000
193   Seychelles 84,000
194   Isle of Man (UK) 80,000
195   Dominica 67,000
196   American Samoa (US) 67,000
197   Bermuda (UK) 65,000
198   Marshall Islands 62,000
199   Guernsey (UK) 61,811
200   Greenland (Denmark) 57,000
201   Cayman Islands (UK) 56,000
202   Saint Kitts and Nevis 52,000
203   Faroe Islands (Denmark) 48,797
204   Liechtenstein 35,700
205   Monaco 33,000
206   Turks and Caicos Islands (UK) 33,000
207   San Marino 30,800
208   Gibraltar (UK) 31,000
209   British Virgin Islands (UK) 23,000
210   Cook Islands (New Zealand) 20,000
211   Palau 20,000
212   Anguilla (UK) 15,000
213   Tuvalu 10,000
214   Nauru 10,000
215   Saint Helena (UK) 6,600
216   Montserrat (UK) 5,900
217   Falkland Islands (UK) 3,000
218   Niue (New Zealand) 1,500
219   Tokelau (New Zealand) 1,400
220   Vatican City 800
221   Pitcairn Islands (UK) 50

References

edit
  1. ^ a b Schünemann HJ, Hill SR, Kakad M, et al. (January 2007). "WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus". Lancet Infect Dis. 7 (1): 21–31. doi:10.1016/S1473-3099(06)70684-3. PMC 7106493. PMID 17182341.
  2. ^ a b de Jong JC, Beyer WE, Rimmelzwaan GF, Fouchier RA, Osterhaus AD (January 2004). "[Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza]". Ned Tijdschr Geneeskd (in Dutch and West Flemish). 148 (2): 73–9. PMID 14753128.
  3. ^ a b c Ward P, Small I, Smith J, Suter P, Dutkowski R (February 2005). "Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic". J. Antimicrob. Chemother. 55 (Suppl 1): i5–i21. doi:10.1093/jac/dki018. PMID 15709056.
  4. ^ a b Harrod ME, Emery S, Dwyer DE (November 2006). "Antivirals in the management of an influenza pandemic". Med. J. Aust. 185 (10 Suppl): S58–61. doi:10.5694/j.1326-5377.2006.tb00709.x. PMID 17115954. S2CID 7932602.